RELX stock slips 2.01% from latest report as outlook holds

RELX stock traded at 35.09 euros on Lang & Schwarz at 18:10 CET on Tuesday, November 3, 2026, down 2.01 percent from the 35.81-euro quote in the latest own report published on Monday, November 2. Investors can follow the real-time quote of RELX stock.

What changed since the last report

The latest report said RELX had maintained its full-year outlook after 7 percent underlying revenue growth in the first nine months of 2026. Legal grew 10 percent, Risk 8 percent and Scientific, Technical & Medical 6 percent, while Exhibitions advanced 4 percent.

Management continues to expect strong underlying revenue growth, strong adjusted operating profit growth and strong constant-currency adjusted earnings-per-share growth. The previous report linked the outlook to continued demand for higher-value analytics and decision tools rather than to a single division.

AI remains the key execution test

RELX describes its business as information-based analytics and decision tools for professional and business customers, serving clients in more than 180 countries, according to the RELX investor overview. The investment question is whether adoption of AI-enabled legal, risk and scientific products can support durable revenue and margin growth.

Legal and Risk currently provide the strongest operating momentum in the latest company update. In Scientific, Technical & Medical, product adoption and research activity remain important indicators for the group's ability to convert technology investment into commercial results.

The wider UK equity market remains the relevant backdrop for London-listed shares; see current FTSE 100 market reports.

More news and analyses on RELX stock.